Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fear | 15 | 2024 | 272 | 4.600 |
Why?
|
| Extinction, Psychological | 15 | 2024 | 104 | 4.070 |
Why?
|
| Prefrontal Cortex | 6 | 2019 | 164 | 2.450 |
Why?
|
| Limbic System | 6 | 2016 | 31 | 2.240 |
Why?
|
| Action Potentials | 14 | 2019 | 246 | 1.990 |
Why?
|
| Neurons | 13 | 2019 | 1263 | 1.880 |
Why?
|
| Synapses | 6 | 2019 | 185 | 1.750 |
Why?
|
| Hippocampus | 8 | 2024 | 594 | 1.660 |
Why?
|
| Neuronal Plasticity | 3 | 2019 | 126 | 1.470 |
Why?
|
| Receptors, Metabotropic Glutamate | 4 | 2015 | 26 | 1.420 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2024 | 50 | 1.330 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2024 | 1766 | 1.130 |
Why?
|
| Cerebral Cortex | 5 | 2015 | 306 | 1.060 |
Why?
|
| Conditioning, Classical | 4 | 2019 | 67 | 1.020 |
Why?
|
| Thalamus | 5 | 2015 | 34 | 0.990 |
Why?
|
| Rats | 20 | 2024 | 3735 | 0.960 |
Why?
|
| Glutamic Acid | 5 | 2015 | 131 | 0.900 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2023 | 41 | 0.800 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2023 | 55 | 0.790 |
Why?
|
| Animals | 32 | 2024 | 16992 | 0.760 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2023 | 568 | 0.760 |
Why?
|
| Interneurons | 5 | 2004 | 65 | 0.700 |
Why?
|
| Association Learning | 2 | 2019 | 35 | 0.690 |
Why?
|
| Benzimidazoles | 2 | 2023 | 43 | 0.660 |
Why?
|
| Tetrazoles | 2 | 2023 | 46 | 0.660 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2019 | 135 | 0.620 |
Why?
|
| Patch-Clamp Techniques | 8 | 2016 | 228 | 0.530 |
Why?
|
| Astrocytes | 6 | 2012 | 244 | 0.520 |
Why?
|
| Receptor, EphB2 | 1 | 2015 | 6 | 0.470 |
Why?
|
| Male | 17 | 2024 | 23409 | 0.460 |
Why?
|
| Pyramidal Cells | 3 | 2008 | 65 | 0.450 |
Why?
|
| Amygdala | 1 | 2015 | 125 | 0.430 |
Why?
|
| Somatosensory Cortex | 2 | 2007 | 26 | 0.430 |
Why?
|
| Memory | 3 | 2010 | 174 | 0.430 |
Why?
|
| Excitatory Postsynaptic Potentials | 3 | 2015 | 80 | 0.410 |
Why?
|
| Neocortex | 4 | 2000 | 27 | 0.380 |
Why?
|
| Receptors, Muscarinic | 1 | 2012 | 16 | 0.370 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1070 | 0.360 |
Why?
|
| KCNQ Potassium Channels | 1 | 2010 | 5 | 0.330 |
Why?
|
| Presynaptic Terminals | 2 | 2004 | 54 | 0.330 |
Why?
|
| Biphenyl Compounds | 2 | 2023 | 53 | 0.320 |
Why?
|
| RNA, Small Interfering | 2 | 2024 | 436 | 0.290 |
Why?
|
| Acoustic Stimulation | 3 | 2017 | 78 | 0.280 |
Why?
|
| Organ Culture Techniques | 3 | 2012 | 101 | 0.250 |
Why?
|
| Cues | 2 | 2019 | 81 | 0.250 |
Why?
|
| Calcium | 5 | 1999 | 491 | 0.250 |
Why?
|
| Neural Pathways | 2 | 2019 | 138 | 0.250 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2005 | 4 | 0.240 |
Why?
|
| Receptors, Purinergic P1 | 2 | 2015 | 6 | 0.230 |
Why?
|
| RNA, Messenger | 4 | 2017 | 1271 | 0.220 |
Why?
|
| Receptors, GABA-B | 1 | 2004 | 11 | 0.220 |
Why?
|
| Electrophysiology | 4 | 2008 | 138 | 0.220 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2024 | 35 | 0.210 |
Why?
|
| Neural Inhibition | 2 | 2001 | 48 | 0.210 |
Why?
|
| Excitatory Amino Acid Antagonists | 4 | 2013 | 92 | 0.210 |
Why?
|
| Corticosterone | 1 | 2024 | 90 | 0.210 |
Why?
|
| Pituitary-Adrenal System | 1 | 2023 | 41 | 0.200 |
Why?
|
| Stress, Psychological | 2 | 2023 | 661 | 0.200 |
Why?
|
| Faculty | 1 | 2023 | 105 | 0.190 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1999 | 10 | 0.190 |
Why?
|
| Electric Stimulation | 3 | 2015 | 186 | 0.180 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2007 | 43 | 0.180 |
Why?
|
| Receptors, Neurotransmitter | 2 | 1997 | 23 | 0.160 |
Why?
|
| Mice | 6 | 2015 | 6644 | 0.150 |
Why?
|
| Intracellular Membranes | 2 | 1996 | 36 | 0.150 |
Why?
|
| Cytokines | 1 | 2023 | 678 | 0.150 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 209 | 0.140 |
Why?
|
| Reward | 1 | 2019 | 112 | 0.140 |
Why?
|
| Receptors, Nicotinic | 1 | 1999 | 114 | 0.140 |
Why?
|
| Cholinergic Agents | 2 | 2012 | 8 | 0.130 |
Why?
|
| Inflammation | 1 | 2023 | 758 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 1596 | 0.130 |
Why?
|
| Exploratory Behavior | 1 | 2017 | 78 | 0.130 |
Why?
|
| omega-Conotoxins | 1 | 1996 | 4 | 0.130 |
Why?
|
| Maze Learning | 1 | 2017 | 113 | 0.130 |
Why?
|
| Avoidance Learning | 1 | 2017 | 70 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2017 | 575 | 0.120 |
Why?
|
| Random Allocation | 1 | 2015 | 147 | 0.110 |
Why?
|
| Mental Recall | 1 | 2015 | 84 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 151 | 0.110 |
Why?
|
| Microelectrodes | 1 | 2015 | 22 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 36 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2015 | 171 | 0.110 |
Why?
|
| Evoked Potentials | 2 | 2005 | 91 | 0.110 |
Why?
|
| Students | 2 | 2023 | 626 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2015 | 102 | 0.110 |
Why?
|
| Time Factors | 2 | 2017 | 1857 | 0.100 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 239 | 0.100 |
Why?
|
| Female | 3 | 2023 | 24698 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 934 | 0.100 |
Why?
|
| AIDS Dementia Complex | 1 | 2014 | 116 | 0.100 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 59 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2012 | 77 | 0.090 |
Why?
|
| Adenosine | 2 | 2005 | 62 | 0.090 |
Why?
|
| Anthracenes | 1 | 2010 | 15 | 0.080 |
Why?
|
| Potassium Channel Blockers | 1 | 2010 | 35 | 0.080 |
Why?
|
| Aminopyridines | 1 | 2010 | 26 | 0.080 |
Why?
|
| Analgesics | 1 | 2010 | 55 | 0.080 |
Why?
|
| Rats, Wistar | 3 | 2000 | 283 | 0.080 |
Why?
|
| Receptors, Glutamate | 3 | 2000 | 28 | 0.080 |
Why?
|
| Biomedical Research | 1 | 2015 | 502 | 0.080 |
Why?
|
| Electroshock | 1 | 2008 | 15 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2008 | 97 | 0.070 |
Why?
|
| Receptors, Presynaptic | 1 | 2007 | 4 | 0.070 |
Why?
|
| Xanthenes | 1 | 2007 | 11 | 0.070 |
Why?
|
| Cyclopropanes | 1 | 2007 | 46 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2007 | 40 | 0.060 |
Why?
|
| Glycine | 1 | 2007 | 47 | 0.060 |
Why?
|
| Amino Acids | 1 | 2007 | 148 | 0.060 |
Why?
|
| Osmolar Concentration | 2 | 1996 | 52 | 0.060 |
Why?
|
| Gene Expression | 2 | 1999 | 701 | 0.060 |
Why?
|
| Baclofen | 1 | 2004 | 9 | 0.050 |
Why?
|
| Mice, Inbred ICR | 2 | 2001 | 44 | 0.050 |
Why?
|
| Humans | 5 | 2023 | 43102 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 61 | 0.050 |
Why?
|
| GABA Antagonists | 2 | 2000 | 29 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2012 | 1621 | 0.050 |
Why?
|
| Communication | 1 | 2023 | 210 | 0.040 |
Why?
|
| Parvalbumins | 1 | 2001 | 17 | 0.040 |
Why?
|
| Dendrites | 1 | 2001 | 57 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2000 | 652 | 0.040 |
Why?
|
| Lysine | 1 | 2001 | 119 | 0.040 |
Why?
|
| Reaction Time | 1 | 2001 | 157 | 0.040 |
Why?
|
| Axons | 1 | 2001 | 117 | 0.040 |
Why?
|
| Receptors, GABA-A | 1 | 2000 | 65 | 0.040 |
Why?
|
| Synaptic Transmission | 1 | 2000 | 149 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2008 | 2157 | 0.040 |
Why?
|
| Nerve Net | 1 | 2000 | 101 | 0.040 |
Why?
|
| Tetrodotoxin | 1 | 1999 | 22 | 0.040 |
Why?
|
| Cholecystokinin | 1 | 1999 | 16 | 0.040 |
Why?
|
| Acetylcholine | 1 | 1999 | 77 | 0.040 |
Why?
|
| DNA Primers | 1 | 1998 | 294 | 0.030 |
Why?
|
| Cell Communication | 1 | 1998 | 114 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 1996 | 8 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 1996 | 55 | 0.030 |
Why?
|
| Receptors, Purinergic | 1 | 1995 | 6 | 0.030 |
Why?
|
| Cycloleucine | 1 | 1995 | 2 | 0.030 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 10 | 0.030 |
Why?
|
| Kainic Acid | 1 | 1995 | 48 | 0.030 |
Why?
|
| School Admission Criteria | 1 | 2015 | 10 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 1995 | 224 | 0.030 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 59 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2015 | 32 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1995 | 75 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 1995 | 206 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 195 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2008 | 352 | 0.030 |
Why?
|
| Peptides | 1 | 1996 | 372 | 0.020 |
Why?
|
| Brain Tissue Transplantation | 1 | 2012 | 4 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 95 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 532 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2015 | 1413 | 0.020 |
Why?
|
| Motor Activity | 1 | 2012 | 437 | 0.020 |
Why?
|
| HIV-1 | 1 | 2014 | 755 | 0.020 |
Why?
|
| Thionucleotides | 1 | 2008 | 8 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 529 | 0.020 |
Why?
|
| Propranolol | 1 | 2008 | 18 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 54 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 150 | 0.020 |
Why?
|
| Conditioning, Operant | 1 | 2008 | 90 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2008 | 127 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 159 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 373 | 0.010 |
Why?
|
| Anxiety | 1 | 2012 | 874 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 5080 | 0.010 |
Why?
|
| GABA Agonists | 1 | 2000 | 21 | 0.010 |
Why?
|
| Receptors, AMPA | 1 | 2000 | 58 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2000 | 15 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 94 | 0.010 |
Why?
|
| Seizures | 1 | 2000 | 79 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2000 | 222 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 12222 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 13872 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 386 | 0.010 |
Why?
|
| Aging | 1 | 2000 | 783 | 0.010 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 1994 | 13 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1994 | 35 | 0.010 |
Why?
|
| Brain | 1 | 1994 | 1472 | 0.000 |
Why?
|